$BKNG

MYLOD ROBERT J JR sold $207K of BKNG (indirect holdings)

MYLOD ROBERT J JR sold 1,000 indirectly-held shares of Booking Holdings Inc. (BKNG) at $206.70 ($0.21M total) on 2026-08-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MYLOD ROBERT J JR
Published Aug 6, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BKNG
Neutral
high confidence
Mentioned
$BKNG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BKNGNeutralLow
01

Why it matters

The disclosure adds transparency on insider activity but does not introduce new operational, financial, or regulatory information about Booking Holdings.

02

Market read

Traders may note the optics of insider selling, but the 10b5-1 structure and lack of fundamental updates make it low signal.

03

What to watch

The article provides no context on total holdings, frequency of prior sales, or whether the sale was part of a larger scheduled program beyond this single transaction.

Relevance 3/10Novelty 2/10Timing: Filed on 2026-08-06, covering a sale executed 2026-08-05.

Background

The article is an SEC Form 4 insider transaction disclosure for Booking Holdings director MYLOD ROBERT J JR, executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$BKNGNeutralHigh confidence
Context

Booking Holdings disclosed an insider open-market sale of 1,000 shares at $206.70 on a 10b5-1 plan filed via Form 4.

Expected impact

Likely negligible near-term impact; any effect is more about optics than new fundamentals.

Evidence & confidence

The filing is a pre-arranged 10b5-1 sale with a small share count relative to typical market liquidity, and it does not include new company guidance, deals, or regulatory actions.

Market effects

No clear read-through to the online travel sector beyond routine insider trading optics.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with private concerns, so traders may watch for clustering of sales around other negative signals.

Key entities

  • Booking Holdings Inc.

    Subject of the Form 4 insider transaction disclosure.

  • MYLOD ROBERT J JR

    Director who sold 1,000 shares at $206.70 via an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BKNGMed

FTC Targets Booking Holdings in Hotel-Booking Advertising Probe

The FTC is investigating Booking Holdings' Priceline over its relationship with Guest Reservations, focusing on advertising practices that may mislead consumers. The company disputes the FTC's position and is discussing a resolution. Potential penalties could exceed $500 million, according to a source. Booking Holdings has warned of possible financial and operational impacts.

$BKNGMed

FTC Scrutiny on Priceline Subsidiary Puts Booking Holdings (BKNG

Booking Holdings (BKNG) faces FTC scrutiny over alleged deceptive practices by Priceline.com and Guest Reservations. The company's stock is trading at $156.58, 33.1% below its GF Value™ of $234.14, indicating undervaluation. BKNG has a GF Score™ of 95, reflecting strong financial health and growth. Insider sales totaled $56.7 million over the past year, with mixed activity from institutional investors.

$BKNGMed

FTC Investigates Booking Holdings (BKNG) Over Potentially Decept

The FTC is investigating Booking Holdings (BKNG) for allegedly deceptive ads that redirect users to third-party platforms with hidden fees. BKNG's stock is trading at $157.04, with an intrinsic value of $234.14, according to GF Value™, suggesting a 32.9% undervaluation. The company has a GF Score™ of 95, indicating strong fundamentals, but faces regulatory risks and recent insider selling.